Pathophysiology, Genetics & Classification

Question	Answer
1. What is the fundamental immune mechanism driving Post-Streptococcal Glomerulonephritis (PSGN)?	It is an immune-complex-mediated glomerulonephritis characterized by deposition of circulating or in situ formed immune complexes containing nephritogenic streptococcal antigens along the glomerular basement membrane and mesangium.
2. Name two specific nephritogenic antigens derived from Group A Streptococcus implicated in PSGN pathogenesis.	1. Nephritis-associated plasmin receptor (NAPlr). 2. Pyrogenic exotoxin B (SpeB).
3. How does the classical complement pathway get activated in acute PSGN?	Streptococcal antigens combine with antibodies to form immune complexes that directly fix and activate the classical complement cascade, leading to profound consumption and depression of serum C3 levels.
4. What is the role of the alternative complement pathway in the pathophysiology of PSGN?	Nephritogenic antigens and zymogen activation lead to local amplification via the alternative complement pathway, which further depletes serum C3 while often sparing early complement components like C1q and C4.
5. What ultrastructural pathognomonic finding is visualized on electron microscopy in acute PSGN?	Subepithelial electron-dense deposits shaped like "humps" (hump-like deposits) along the glomerular basement membrane.
6. Describe the characteristic immunofluorescence staining pattern seen in renal biopsy specimens of PSGN.	A coarse granular, "starry sky" or "garland" pattern of IgG and C3 deposition along the glomerular capillary loops and in the mesangium.
7. VIVA TRAP: Can PSGN present with normal serum C3 levels at initial clinical presentation?	YES. While >90% of patients show hypocomplementemia (low C3) in the first week, an estimated 5–10% of biopsy-proven cases can present with normal serum C3 levels due to timing or transient fluctuations.
8. What is the typical pathophysiological explanation for the latent period observed between streptococcal infection and the onset of GN?	The latent period of 1 to 2 weeks (following pharyngitis) or 3 to 6 weeks (following skin infection) represents the time required for the host to mount an adaptive humoral immune response and generate nephritogenic immune complexes.
9. What is the fundamental anatomical and functional alteration causing oliguria and fluid retention in AGN?	Acute inflammation causes a marked reduction in the glomerular filtration rate (GFR) due to mesangial expansion, cellular proliferation, and occlusion of capillary lumens, resulting in avid sodium and water reabsorption by the renal tubules.
10. How does the IPNA/ISPN 2023 classification group acute nephritic syndromes regarding histological severity?	They are categorized by the extent of crescent formation (extracapillary proliferation), where >50% crescents defines rapidly progressive glomerulonephritis (RPGN), requiring urgent aggressive intervention.
11. What pathophysiological mechanism accounts for macroscopic hematuria (cola-colored urine) in acute glomerulonephritis?	Glomerular capillary wall damage allows the passage of dysmorphic red blood cells through the filtration barrier into Bowman's space, which are subsequently converted to acid hematin in the acidic tubular fluid.
12. Why is hypertension in acute glomerulonephritis primarily categorized as volume-dependent?	Because the primary driver is acute sodium and water retention secondary to a precipitous drop in GFR, leading to expanded extracellular fluid volume and increased cardiac output.
13. VIVA TRAP: Are serum ASOT titers equally elevated following streptococcal pharyngitis and streptococcal pyoderma?	NO. ASOT (Anti-Streptolysin O titers) reliably rises after pharyngitis but is frequently normal or only weakly positive after skin infections (impetigo), because cholesterol in the skin neutralizes streptolysin O; anti-DNase B is a superior marker for pyoderma.
14. What genetic or familial susceptibility factors are associated with atypical presentations or poor outcomes in post-infectious GN?	Mutations or variants in complement regulatory genes (such as Factor H, Factor I, or CFHR proteins) can predispose patients to an unremitting course or mimic dense deposit disease / C3 glomerulopathy.
15. How does the pathophysiology of C3 Glomerulopathy differ from classic post-streptococcal glomerulonephritis despite both showing low C3?	C3 glomerulopathy involves primary dysregulation and overactivation of the alternative complement pathway (often via genetic mutations or autoantibodies like C3 nephritic factor), rather than a transient post-infectious immune complex deposition.
16. What cellular elements constitute the "crescents" seen in severe forms of acute nephritic syndrome on renal histopathology?	Extracapillary proliferation composed of proliferating parietal epithelial cells, infiltrating macrophages, and monocytes within Bowman's space, compressing the glomerular tuft.
17. Explain the pathological basis of mild non-pitting periorbital edema characteristically seen upon waking in children with AGN.	Periorbital tissues possess loose connective tissue and low tissue pressure, making them exceptionally sensitive to early morning fluid redistribution and mild intravascular volume expansion.
18. What is the exact expected timeline for the normalization of low serum C3 levels according to IPNA/ISPN guidelines, and what does a longer duration signify?	Serum C3 levels must return to normal within 6 to 8 weeks; failure to normalize beyond this window indicates an alternative diagnosis such as membranoproliferative glomerulonephritis (MPGN) or C3 glomerulopathy.
19. VIVA TRAP: Does the presence of subepithelial hump-like deposits on electron microscopy completely rule out IgA nephropathy?	NO. While classic for PSGN, subepithelial or mesangial deposits can sometimes co-exist or overlap, and definitive classification relies on immunofluorescence showing predominant IgA deposition for IgA nephropathy.

Clinical History & Bedside Evaluation

Question	Answer
1. What constitutes the classic nephritic triad during the history-taking of a child presenting with acute glomerulonephritis?	1. Sudden onset of cola-colored or smoky urine (macroscopic hematuria). 2. Facial puffiness, particularly prominent periorbital edema upon waking. 3. Reduced urine output (oliguria).
2. How does the chronologic progression and preceding infectious history differ between pharyngeal and cutaneous streptococcal triggers in PSGN?	A post-pharyngitis latent period typically spans 1 to 2 weeks, whereas a post-pyoderma or impetigo latent period is characteristically longer, spanning 3 to 6 weeks.
3. What specific historical inquiries regarding recent family or community health must be made when evaluating a suspected post-streptococcal case?	Specific inquiries must target recent documented episodes of sore throat, scarlet fever, skin boils, impetigo, or similar acute joint and urinary complaints among close contacts or schoolmates.
4. What specific dietary recall and fluid intake parameters must be obtained during the bedside clinical history of a child with oliguric AGN?	Dietary recall must accurately quantify salt and water intake, oral fluid tolerance, and total estimated 24-hour fluid balance to guide immediate restrictive management.
5. What essential elements must be screened in the perinatal and early developmental history of a toddler presenting with features mimicking acute nephritis?	1. Birth weight and gestational age to assess baseline nephron endowment. 2. Any history of antenatal oligohydramnios or congenital urinary tract anomalies. 3. Early developmental milestones to rule out syndromic causes like Alport syndrome.
6. How should a family pedigree be constructed when investigating a child with suspected glomerulonephritis, and what inherited disorders are being ruled out?	The pedigree must map out three generations, actively screening for a family history of early-onset end-stage renal disease, unexplained hematuria, deafness, or recurrent nephritic episodes suggestive of Alport syndrome or familial IgA nephropathy.
7. What historical red flags distinguish acute nephritic syndrome from nephrotic syndrome or acute kidney injury of non-glomerular etiology?	1. Presence of macroscopic dark urine (cola-colored) rather than frothy urine. 2. Preceding systemic infection with a distinct latent interval. 3. Accompanying hypertensive symptoms like severe headache or vomiting.
8. What specific symptoms in the history indicate that hypertension has progressed to a neurological hypertensive emergency or encephalopathy?	Throbbing occipital or generalized headaches, repeated vomiting, acute visual blurring, lethargy, focal neurological deficits, or generalized tonic-clonic seizures.
9. What historical clues help differentiate the hematuria of acute glomerulonephritis from lower urinary tract bleeding or urinary tract infection?	AGN hematuria is characteristically painless, total throughout the urinary stream, and accompanied by smoky or cola-colored discoloration rather than bright red blood, clots, or dysuria.
10. What predisposing environmental and socioeconomic risk factors should be elicited during history taking for post-infectious GN in developing regions?	Overcrowding, poor personal hygiene, low socioeconomic status, warm humid climates favoring skin impetiginization, and lack of prompt antibiotic access for streptococcal infections.
11. VIVA TRAP: Does a negative history of sore throat or skin lesions completely rule out post-streptococcal glomerulonephritis?	NO. Up to 25 to 30% of children with PSGN have subclinical or completely asymptomatic preceding streptococcal infections, rendering a negative infection history unreliable.
12. What historical indicators point toward acute circulatory congestion and impending pulmonary edema during bedside evaluation?	Progressive breathlessness, orthopnea, nocturnal cough, and a sense of chest tightness or oppression that developed alongside acute fluid retention.
13. What historical data regarding medication use must be specifically captured to rule out drug-induced acute interstitial nephritis or vasculitis?	Detailed inquiry regarding recent ingestion of over-the-counter NSAIDs, herbal concoctions, or antibiotics that can cause acute kidney injury mimicking an acute nephritic presentation.
14. What constitutional symptoms in the history can help differentiate uncomplicated PSGN from systemic autoimmune conditions like systemic lupus erythematosus?	The presence of prolonged high-grade fever, unexplained weight loss, mucosal ulcers, photosensitive rashes, or symmetrical polyarthritis points away from isolated PSGN and toward SLE nephritis.
15. VIVA TRAP: Can a patient report normal daily urinary frequency while experiencing significant oliguria and declining renal function?	YES. Parents may misinterpret urinary frequency or urinary urgency (pollakiuria) for normal or increased volume, whereas true volumetric measurement reveals severe oliguria (<0.5 mL/kg/hr).
16. What specific questions should be asked regarding previous urinary abnormalities in the patient's past medical history to identify pre-existing chronic kidney disease?	Inquiries must target any prior routine urinalysis showing microscopic hematuria or proteinuria, previous unexplained episodes of facial swelling, or past urinary tract infections.
17. What historical markers of gastrointestinal involvement require careful documentation when assessing acute nephritic children for hemolytic uremic syndrome?	A preceding history of bloody diarrhea, ingestion of undercooked meat, unpasteurized milk exposure, or swimming in contaminated water pools.
18. VIVA TRAP: Is the presence of macroscopic hematuria directly proportional to the severity of glomerular injury or long-term renal prognosis in PSGN?	NO. The intensity of macroscopic hematuria (cola-colored urine) correlates poorly with the degree of histological damage, hypertension severity, or long-term renal outcome.

Physical Examination & Bedside Signs

Question	Answer
1. How should anthropometric assessment be systematically integrated into the physical examination of a child suspected of having acute glomerulonephritis?	1. Measure baseline weight precisely to track acute fluid retention versus mobilization. 2. Plot weight against height on growth charts to establish baseline nutritional status. 3. Re-weigh the child daily at the same time using the same scale to monitor diuresis and fluid balance.
2. What characteristic physical inspection finding is classically observed on the face of a child with acute glomerulonephritis upon waking up in the morning?	Mild, non-pitting periorbital edema primarily resulting from gravity-dependent fluid redistribution and low interstitial tissue pressure in the loose periorbital tissues overnight.
3. How do you distinguish the edema of acute glomerulonephritis from the generalized dependent edema typically seen in nephrotic syndrome during physical inspection?	AGN edema is usually mild, predominantly periorbital and facial, and non-pitting, whereas nephrotic syndrome features generalized, severe pitting anasarca with prominent dependent edema, scrotal/labial swelling, and ascites.
4. What specific physical examination maneuver is mandatory when evaluating the blood pressure of a pediatric patient with suspected acute glomerulonephritis?	Using an appropriately sized blood pressure cuff (bladder width covering 40% of upper arm circumference and length covering 80–100%) and comparing the measured value against age-, sex-, and height-specific centile charts, where hypertension is defined as a reading greater than the 95th centile plus 12 mmHg.
5. What clinical signs on physical examination indicate that volume overload and salt retention have progressed to acute circulatory congestion?	1. Elevated jugular venous pressure (JVP). 2. Basal lung crackles or rales. 3. A summation gallop rhythm (S3 or S4 gallop). 4. Tender, congestive hepatomegaly.
6. How do you properly elicit and interpret a third heart sound (S3 gallop) during cardiac auscultation in a child with hypervolemic AGN?	Listen at the cardiac apex using the bell of the stethoscope with the patient in the left lateral decubitus position; an S3 gallop indicates early rapid ventricular filling against a non-compliant, volume-overloaded ventricle.
7. What pathognomonic neurological signs must examiners actively screen for when assessing a child with acute post-streptococcal glomerulonephritis and severe headache?	Signs of hypertensive encephalopathy, which include altered sensorium, visual blurring, focal neurological deficits, hyperreflexia, clonus, and generalized tonic-clonic seizures.
8. What bedside inspection and palpation findings characterize the abdomen of a child experiencing acute circulatory congestion secondary to salt and water retention?	Inspection may reveal abdominal distension or shifting dullness indicating mild ascites, while gentle palpation reveals a smooth, tender hepatomegaly due to acute hepatic congestion.
9. How should the physical examination assess the respiratory system to rule out impending pulmonary edema in an oliguric child with AGN?	1. Inspect for tachypnea and increased work of breathing (subcostal retractions). 2. Auscultate for bilateral basal fine crackles that progress superiorly as pulmonary congestion worsens.
10. What specific cutaneous inspection findings must be actively searched for on the skin during the physical examination to identify a preceding streptococcal portal of entry?	Look for honey-colored crusted lesions, pustules, or vesicular rashes indicative of pyoderma or impetigo, as well as fading erythema from healed pharyngitis or infected insect bites.
11. How do you systematically evaluate peripheral pulses and capillary refill time during the cardiovascular examination of a hypertensive child with AGN?	Palpate all peripheral pulses (carotid, radial, femoral, dorsalis pedis) to ensure they are bounding or normal in volume due to hypervolemia, and check capillary refill time to rule out early circulatory compromise.
12. What bedside sign distinguishes true cardiomegaly from acute circulatory congestion during the physical examination of the heart?	True cardiomegaly presents with a laterally displaced, hyperdynamic apex beat, whereas acute congestion in AGN typically shows a normal apex location with preserved contractility and a gallop rhythm driven by pure volume overload.
13. VIVA TRAP: Is hepatomegaly in a patient with AGN caused by primary intrinsic liver pathology?	NO. The hepatomegaly is secondary to acute right-sided heart failure and systemic venous congestion resulting from severe intravascular volume overload.
14. What specific bedside inspection findings on the eyelids and conjunctiva help differentiate nephritic facial puffiness from allergic angioedema or local trauma?	Nephritic puffiness presents as symmetric, pale, non-inflammatory swelling of the periorbital tissue without conjunctival chemosis, erythema, pruritus, or local signs of trauma.
15. How does physical examination evaluate the severity of oliguria when direct hourly catheter measurement is not immediately available at the bedside?	By inspecting the color (cola-colored or smoky red) and volume of voided urine in a collection bag, noting a significant drop in urine output below 0.5 mL/kg/h alongside rapid weight gain.
16. What neurological examination findings differentiate primary CNS pathology from a secondary hypertensive emergency in a convulsing child with AGN?	Hypertensive encephalopathy typically presents with acute-onset generalized seizures accompanied by extreme blood pressure elevation (>95^{th} centile + 12 mmHg) and normal focal exam between episodes, resolving rapidly once blood pressure is controlled.
17. What specific auscultatory maneuvers should be performed over the abdomen and flank regions during the vascular examination of a hypertensive child?	Auscultate for renal artery bruits using the diaphragm of the stethoscope to rule out renovascular hypertension as a secondary cause of severe acute blood pressure elevation.
18. How is skin turgor and hydration status accurately assessed on physical examination in a child who presents with both fluid overload (edema) and oliguria?	Assess mucous membranes for moisture and evaluate skin turgor over the chest or abdomen, keeping in mind that despite peripheral edema, intravascular compartment volume is expanded, making skin turgor tests unreliable for dehydration.

Diagnostic Criteria & Investigations

Question	Answer
1. What are the hallmark urinary sediment findings on microscopy that confirm acute nephritic syndrome in a child?	1. Dysmorphic red blood cells (acanthocytes, target cells) indicating glomerular bleeding. 2. Red blood cell casts which are pathognomonic of acute glomerulonephritis. 3. Granular and white blood cell casts reflecting active tubular and glomerular inflammation.
2. VIVA TRAP: If serum C3 levels remain persistently low beyond 8 weeks in a child presumed to have PSGN, what is your mandatory next diagnostic step?	1. MUST perform a renal biopsy. 2. Persistent hypocomplementemia beyond 8 weeks mandates a tissue diagnosis to rule out membranoproliferative glomerulonephritis (MPGN), lupus nephritis, or C3 glomerulopathy.
3. How do antistreptolysin O (ASO) titers differ in diagnostic utility between pharyngeal streptococcal infections and skin pyoderma?	1. ASO titers rise reliably following pharyngitis (positive in 70-80% of cases). 2. They are frequently unreliable or minimally elevated following skin pyoderma because cutaneous lipids inhibit streptolysin O; instead, anti-DNase B titers should be checked.
4. What is the gold standard diagnostic investigation to confirm the histological diagnosis and assess the severity of acute glomerulonephritis when atypical features are present?	1. Percutaneous renal biopsy. 2. Histopathology typically demonstrates diffuse endocapillary proliferative glomerulonephritis with characteristic subepithelial immune complex "humps" on electron microscopy.
5. What cutoff values and definitions are used to define significant proteinuria in the evaluation of acute nephritic syndrome versus nephrotic syndrome?	1. In AGN, proteinuria is usually non-nephrotic, defined as urine protein-to-creatinine ratio (UPCR) between 0.2 and 2.0 mg/mg. 2. True nephrotic range proteinuria (UPCR > 2.0 mg/mg or 40 mg/m²/hr) is rarely seen in classic PSGN and suggests alternative glomerulopathies.
6. How does the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) profile assist in the laboratory assessment of acute nephritis?	1. ESR is almost universally elevated during the acute phase of PSGN reflecting systemic inflammation. 2. CRP may be normal or mildly elevated, making ESR a more sustained and reliable inflammatory marker in this condition.
7. What specific serum biomarker cutoffs and parameters define acute kidney injury (AKI) staging according to KDIGO guidelines in a child with severe AGN?	1. KDIGO AKI staging relies on a rise in serum creatinine ≥ 0.3 mg/dL within 48 hours, a rise to ≥ 1.5 times baseline within the prior 7 days, or urine output < 0.5 mL/kg/h for 6 hours. 2. It helps quantify the degree of renal impairment accompanying the acute nephritic insult.
8. VIVA TRAP: Can a normal ASO titer completely rule out a preceding streptococcal infection in a patient with suspected PSGN?	1. NO. A single normal ASO titer does not rule out PSGN, especially when the preceding infection was cutaneous (impetigo) or if antibiotic therapy was administered early. 2. A panel including anti-DNase B and anti-hyaluronidase antibodies must be evaluated.
9. How do you differentiate post-streptococcal glomerulonephritis from systemic lupus erythematosus (SLE) nephritis using autoantibody profiles?	1. PSGN demonstrates normal serum ANA, anti-dsDNA, and ANCA, whereas SLE nephritis shows high titers of ANA and anti-dsDNA alongside low C3 and C4 levels. 2. Additionally, lupus nephritis typically presents with persistent nephrotic-range proteinuria and multiorgan involvement.
10. VIVA TRAP: Is a renal biopsy mandatory for every child who presents with classical clinical and laboratory features of post-streptococcal glomerulonephritis?	1. NO. Renal biopsy is not routinely required for typical cases presenting with acute nephritic syndrome, macroscopic hematuria, elevated ASO, and depressed C3 that normalizes by 8 weeks. 2. Biopsy is reserved for atypical presentations, rapidly progressive glomerulonephritis, nephrotic syndrome, or persistent hypocomplementemia.
11. What specific laboratory diagnostic findings differentiate Hemolytic Uremic Syndrome (HUS) from Acute Post-Streptococcal Glomerulonephritis?	1. HUS is characterized by microangiopathic hemolytic anemia (schistocytes, low hemoglobin), severe thrombocytopenia, and acute kidney injury with normal or near-normal serum complement C3 levels. 2. In contrast, PSGN exhibits normal platelet counts, absence of schistocytes, and markedly depressed C3 levels.
12. How is rapidly progressive glomerulonephritis (RPGN) distinguished from self-limiting PSGN based on early laboratory trends and imaging?	1. RPGN demonstrates a rapid, relentless escalation in serum creatinine and worsening oliguria over days to weeks, unlike the self-limiting course of uncomplicated PSGN. 2. Ultrasound in RPGN shows preserved or enlarged kidneys with loss of corticomedullary differentiation, while renal biopsy confirms extensive crescent formation (>50% of glomeruli).
13. What specific electrolyte abnormalities must be vigilantly monitored and screened via blood investigations in an oliguric child with acute glomerulonephritis?	1. Hyperkalemia, due to impaired glomerular filtration rate and reduced distal potassium excretion. 2. Hyponatremia (dilutional secondary to water retention) and metabolic acidosis.
14. What specific panel of non-streptococcal serological investigations should be ordered when evaluating a child with acute nephritic syndrome whose complement C3 levels remain normal?	1. Antinuclear antibodies (ANA) and anti-double-stranded DNA (anti-dsDNA) to screen for lupus nephritis. 2. Anti-neutrophil cytoplasmic antibodies (ANCAs: PR3-ANCA and MPO-ANCA) and anti-glomerular basement membrane (anti-GBM) antibodies to evaluate for rapidly progressive crescentic glomerulonephritis. 3. Serum immunoglobulins (especially IgA levels) and cryoglobulins if membranoproliferative or IgA-mediated etiologies are suspected.
15. VIVA TRAP: Can streptozyme testing replace individual antibody titers like ASO, anti-DNAse B, and anti-hyaluronidase in confirming preceding streptococcal infection?	NO. While the streptozyme test screens for multiple streptococcal extracellular antigens simultaneously, it has high false-negative and false-positive rates, making it less reliable than quantitative individual assays (such as ASO for pharyngitis and anti-DNAse B for pyoderma) for accurate retrospective confirmation.
16. What distinct light microscopy, immunofluorescence, and electron microscopy findings differentiate Post-Streptococcal Glomerulonephritis from IgA Nephropathy on renal biopsy?	1. Light microscopy in PSGN shows diffuse endocapillary proliferative glomerulonephritis with neutrophilic infiltration, whereas IgA nephropathy typically shows mesangial proliferation. 2. Immunofluorescence in PSGN demonstrates characteristic "lumpy-bumpy" granular IgG and C3 deposition along the glomerular basement membrane and mesangium, compared to predominant mesangial IgA deposition in IgA nephropathy. 3. Electron microscopy in PSGN reveals pathognomonic subepithelial electron-dense immune complex humps.
17. What distinct urine microscopy findings and red cell characteristics help differentiate glomerular hematuria from non-glomerular (urological) hematuria in a child presenting with smoky urine?	1. Presence of dysmorphic red blood cells (e.g., acanthocytes, target cells, or G1 cells) exceeding 40% on phase-contrast microscopy strongly indicates a glomerular source. 2. Red blood cell casts are pathognomonic for glomerulonephritis and confirm intra-renal origin. 3. Absence of blood clots and the presence of concurrent significant proteinuria further differentiate glomerular bleeding from lower urinary tract causes.

Evidence-Based Management & Pharmacotherapy

Question	Answer
1. What is the initial pharmacological dose and mechanism of action of IV Furosemide when managing acute volume overload in AGN?	1. Administer IV Furosemide at 2-4 mg/kg per dose. 2. It acts by inhibiting the Na+/K+/2Cl- cotransporter in the thick ascending limb of the loop of Henle, promoting rapid natriuresis and reducing intravascular volume.
2. What are the preferred first-line oral and intravenous antihypertensive agents and their respective dosages for managing severe hypertension in acute glomerulonephritis?	1. Oral Nifedipine at 0.25-0.5 mg/kg per dose is used for acute hypertension. 2. IV Labetalol at 0.2-1.0 mg/kg per dose is preferred for rapid intravenous control or hypertensive emergencies.
3. When should IV Sodium Nitroprusside be initiated in a child with AGN, and what critical precautions are mandatory during its administration?	1. It is indicated for refractory hypertensive encephalopathy unresponsive to standard first-line agents. 2. It must be infused via an infusion pump with strict intra-arterial or frequent non-invasive blood pressure monitoring due to the risk of precipitous hypotension and cyanide toxicity.
4. What are the absolute indications for initiating emergency renal replacement therapy (dialysis) in a child with severe acute glomerulonephritis?	1. Refractory hyperkalemia (serum potassium >6.5 mEq/L with ECG changes). 2. Severe refractory fluid overload resulting in pulmonary edema unresponsive to diuretics. 3. Severe uremic symptoms (encephalopathy, pericarditis) or intractable metabolic acidosis.
5. What is the recommended duration and schedule for long-term blood pressure and urinalysis surveillance following an acute episode of PSGN?	1. Blood pressure and urinalysis should be monitored monthly for the first 3 to 6 months. 2. Routine follow-up continues until blood pressure normalizes, edema resolves, and macroscopic hematuria and significant proteinuria completely disappear.
6. What is the mechanism of action of Calcium Channel Blockers like Nifedipine when used for emergency blood pressure reduction in pediatric nephritis?	1. They block L-type voltage-gated calcium channels in vascular smooth muscle cells. 2. This induces systemic arteriolar vasodilation, reduces total peripheral resistance, and rapidly lowers elevated blood pressure without directly compromising renal blood flow.
7. What pharmacological agent is indicated for rapid control of acute hypertensive encephalopathy presenting with seizures in a child with AGN?	1. Immediate blood pressure reduction using IV Labetalol or IV Nicardipine infusion. 2. Administer acute anticonvulsant therapy such as IV Lorazepam (0.1 mg/kg) if active seizure activity persists.
8. What is the potential toxic side-effect profile of prolonged or high-dose loop diuretic therapy, and how is it monitored clinically?	1. Ototoxicity, severe hypokalemia, metabolic alkalosis, and prerenal azotemia from intravascular volume depletion. 2. Monitored through serial serum electrolytes, acid-base status, and clinical assessment of hydration and hearing acuity.
9. VIVA TRAP: Does administering prophylactic antibiotics to asymptomatic siblings of a child with PSGN prevent them from developing glomerulonephritis?	NO. Prophylactic antibiotic treatment of contacts does not alter the incidence of subsequent nephritis, as the immune-mediated glomerular injury is already triggered by host responses to the antecedent streptococcal strain.
10. How should fluid management be adjusted if an oliguric child with AGN develops signs of concurrent dehydration due to vomiting or excessive diuretic use?	1. Temporarily hold loop diuretics. 2. Provide carefully calculated intravenous fluid replacement matching exact measured losses to avoid precipitating acute tubular necrosis or worsening renal failure.
11. What class of antihypertensive medications is typically avoided as a first-line emergency agent in bilateral renal artery stenosis or severe oliguric AKI associated with acute nephritis, and why?	1. ACE inhibitors (ACEIs) and ARBs. 2. They can precipitate profound acute kidney injury and precipitous drops in glomerular filtration rate by preventing efferent arteriolar vasoconstriction in compromised nephrons.
12. VIVA TRAP: Can salt-poor albumin be freely infused alongside diuretics to treat severe periorbital edema and hypoalbuminemia in uncomplicated acute glomerulonephritis?	NEVER. Edema in AGN is driven by primary salt and water retention due to decreased GFR, not by true intravascular protein depletion; albumin infusion will worsen hypertension and precipitate acute pulmonary edema.
13. What specific parameters define successful therapeutic response within the first 48 to 72 hours of hospital admission for acute glomerulonephritis?	1. Restoration of a positive diuresis (brisk urine output). 2. Steady reduction in body weight and resolution of hypertension. 3. Normalization or significant improvement in neurological status and disappearance of congestive symptoms.
14. When treating severe hypertensive encephalopathy refractory to first-line agents in AGN, what are the precise dosing and safety monitoring requirements for Sodium Nitroprusside?	1. Sodium Nitroprusside is initiated via continuous IV infusion at 0.5 mcg/kg/min and titrated upward cautiously to a maximum of 8 mcg/kg/min. 2. Because it breaks down into cyanide and thiocyanate, infusion duration must be minimized, and continuous intra-arterial blood pressure monitoring alongside light-protected delivery tubing is mandatory.
15. What specific pharmacological management and eradication schedule are recommended for treating a documented streptococcal throat or skin infection in a child diagnosed with PSGN?	1. A full 10-day course of oral Phenoxymethylpenicillin (Penicillin V) or a single intramuscular dose of Benzathine Penicillin G (600,000 units if weight <27 kg; 1.2 million units if ≥ 27 kg) is administered. 2. Eradication therapy is indicated to halt ongoing streptococcal transmission to household and community contacts, although it does not alter the natural renal prognosis of the index case.
16. VIVA TRAP: Should corticosteroids or systemic immunosuppressive agents be routinely prescribed in the initial management of typical uncomplicated post-streptococcal glomerulonephritis?	NO. Corticosteroids and immunosuppressive therapy have no proven efficacy in typical, uncomplicated PSGN, as the disease is self-limiting and driven by an immune-complex cascade that resolves spontaneously. Immunosuppression is strictly reserved for biopsy-proven rapidly progressive glomerulonephritis (RPGN) with crescentic transformation.
17. What is the precise formula and clinical rationale for calculating fluid restriction in a child hospitalized with acute oliguric glomerulonephritis and circulatory congestion?	1. Fluid intake is strictly restricted to insensible water loss (calculated as 400 mL/m²/day) plus exactly matched previous 24-hour urine output, plus any measurable extra losses (vomiting or drains). 2. This precise calculation prevents volume expansion, worsening hypertension, and acute pulmonary edema in the setting of diminished glomerular filtration rate.
18. VIVA TRAP: Can short-acting oral Nifedipine be administered via the sublingual route for rapid emergency blood pressure lowering in a child with AGN and hypertensive encephalopathy?	NEVER. Sublingual administration of short-acting Nifedipine causes unpredictable, precipitous drops in systemic blood pressure, leading to catastrophic cerebral and renal hypoperfusion. Oral drops or capsules must be swallowed or alternative titratable IV infusions (like Labetalol) utilized.

High-Yield VIVA TRAPs & Examiner Pitfalls

Question	Answer
1. VIVA TRAP: Can post-streptococcal glomerulonephritis (PSGN) recur in a child who experienced a documented episode years ago?	NO. True recurrences of PSGN are exceptionally rare (<1%) because long-lasting type-specific immunity develops against nephritogenic streptococcal strains; persistent or recurrent hematuria instead points toward IgA nephropathy, Alport syndrome, or membranoproliferative glomerulonephritis (MPGN).
2. VIVA TRAP: What is the mandatory clinical significance if a child's serum C3 complement level fails to return to normal limits within the expected recovery window?	YES, failure of serum C3 to normalize within 6 to 8 weeks strongly contradicts the diagnosis of typical PSGN and mandates a prompt renal biopsy to evaluate for alternative complement-mediated or autoimmune glomerulopathies such as MPGN or C3 glomerulopathy.
3. VIVA TRAP: Should prophylactic antibiotic therapy be routinely administered to asymptomatic family members and school contacts of an index case of PSGN to halt transmission?	NO. Treating asymptomatic contacts with antibiotics does not alter the incidence or community spread of nephritis, as PSGN is a non-suppurative immune-mediated sequel rather than an active direct streptococcal tissue infection.
4. VIVA TRAP: Should first-generation ACE inhibitors or ARBs be administered as initial emergency antihypertensive therapy in a child presenting with severe oliguric AKI and acute nephritis?	NEVER. ACE inhibitors and ARBs reduce efferent arteriolar tone, which can precipitate precipitous drops in glomerular filtration rate and trigger profound, refractory hyperkalemia in oliguric acute kidney injury; they are deferred until volume overload and hyperkalemia are fully resolved.
5. VIVA TRAP: Is it safe to feed a child with acute glomerulonephritis a normal diet containing unrestricted sodium and potassium during the acute oliguric and edematous phase?	NO. Strict dietary restriction of sodium and potassium is mandatory during the acute phase to prevent life-threatening extracellular volume expansion, severe hypertension, pulmonary edema, and fatal cardiac arrhythmias from hyperkalemia.
6. VIVA TRAP: Do persistent microscopic hematuria and low-grade non-nephrotic proteinuria months after an acute episode of PSGN indicate chronic progressive kidney disease?	NO. Mild microscopic hematuria and sub-nephrotic proteinuria can persist harmlessly for several months to years following resolving PSGN and do not signify progressive renal disease as long as blood pressure, complement levels, and renal function remain completely normal.
7. VIVA TRAP: Can fluid restriction formulas in oliguric AGN be calculated solely based on daily body weight without incorporating baseline insensible losses?	NO. Fluid restriction must precisely account for obligatory insensible water loss (calculated as 400 mL/m squared/day) plus exact measured urine output and extra losses to prevent both dangerous volume overload and iatrogenic dehydration.
8. VIVA TRAP: Does a negative throat culture for Streptococcus pyogenes at the time of presentation with acute nephritis rule out post-streptococcal etiology?	YES, in terms of active pharyngeal isolation, but it is expected because the latent period of 1 to 3 weeks means the acute throat infection has already resolved by the time nephritic symptoms appear.
9. VIVA TRAP: Are loop diuretics like IV Furosemide effective in restoring urine output in a child with AGN who has severe, established ischemic acute tubular necrosis?	NO. If severe intrinsic tubular damage or severe glomerular collapse has occurred, high-dose loop diuretics fail to promote diuresis and risk causing ototoxicity; the focus must immediately shift to fluid restriction and renal replacement therapy.
10. VIVA TRAP: Can oral Nifedipine sublingually be safely administered for rapid blood pressure reduction in pediatric hypertensive emergencies associated with acute glomerulonephritis?	NEVER. Sublingual administration of short-acting nifedipine causes uncontrollable, precipitous drops in systemic blood pressure, risking watershed cerebral and renal ischemia; only oral (swallowed) dosing or continuous IV infusions should be used.
11. VIVA TRAP: Is it necessary to perform routine urine cultures on all children presenting with macroscopic hematuria and nephritic syndrome?	NO. Macroscopic hematuria in AGN is sterile glomerular inflammation; routine urine cultures are only indicated if a concurrent urinary tract infection is suspected based on fever, dysuria, or pyuria out of proportion to red cells.
12. VIVA TRAP: Does complete clinical resolution of edema and normalization of blood pressure guarantee that all histological glomerular inflammation has fully resolved?	NO. Histological resolution of endocapillary proliferation and immune complex clearance often lags behind clinical recovery, which is why long-term follow-up of urinalysis and blood pressure is required for at least 12 months.
13. VIVA TRAP: Can PSGN recur in a child who had a confirmed previous episode?	NO. True recurrences of post-streptococcal glomerulonephritis are exceptionally rare (<1%) because lifelong type-specific immunity develops against the nephritogenic M-protein strain; persistent or recurrent hematuria points instead to IgA Nephropathy, Alport Syndrome, or Membranoproliferative Glomerulonephritis.
14. VIVA TRAP: Can a preceding streptococcal skin infection (pyoderma) cause post-streptococcal glomerulonephritis, and how does its latent period differ from streptococcal pharyngitis?	YES. Pyoderma is a well-established antecedent trigger for PSGN. However, its latent period is significantly longer—typically 3 to 6 weeks—compared to the 1 to 2-week latent period following streptococcal pharyngitis.
15. VIVA TRAP: Should a child with acute post-streptococcal glomerulonephritis presenting with gross hematuria and hypertension be subjected to immediate emergency renal biopsy?	NEVER. Renal biopsy is unnecessary in typical cases of PSGN; it is reserved only for atypical presentations such as normal complement levels beyond 8 weeks, rapidly progressive clinical deterioration, absence of latent period, or unexplained nephrotic-range proteinuria.
16. VIVA TRAP: Is true cardiomegaly the primary underlying mechanism when a child with acute glomerulonephritis develops third heart sounds, basal crackles, and hepatomegaly?	NO. The circulatory congestion and cardiac gallop in acute nephritis are driven by acute intravascular volume overload and severe hypertension, not primary myocardial failure or true cardiomegaly.